Trial intelligence / Profile preview

Resveratrol Neuroprotection in Acute Ischemic Stroke

IRCT2016061328430N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of resveratrol in ischemic stroke, sponsored by Kermanshah University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

resveratrol
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT2016061328430N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016061328430N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call